THE PERVASIVELY REGULATED BUSINESS EXCEPTION AND THE FDA
DSpace/Manakin Repository
- DASH Home
- Harvard Law School
- HLS Student Papers
- View Item
THE PERVASIVELY REGULATED BUSINESS EXCEPTION AND THE FDA
| Title: | THE PERVASIVELY REGULATED BUSINESS EXCEPTION AND THE FDA |
| Author: | Wood, Valerie D. |
| Citation: | THE PERVASIVELY REGULATED BUSINESS EXCEPTION AND THE FDA (1995 Third Year Paper) |
| Full Text & Related Files: |
vwood2.pdf (177.2Kb; PDF) 
vwood2.rtf (43.98Kb; RTF file) 
vwood2.html (48.24Kb; HTML)
|
| Abstract: | Section 704 of the Federal Food, Drug and Cosmetic Act authorizes the Food and Drug Administration to conduct inspections of regulated business establishments. In the statute. Congress required that the inspections be at reasonable times and within reasonable limits and in a reasonable manner. Congress further restricted the inspections from including general financial and personnel data, and research data not relating to specially regulated drugs. |
| Terms of Use: | This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA |
| Citable link to this page: | http://nrs.harvard.edu/urn-3:HUL.InstRepos:8889438 |
This item appears in the following Collection(s)
-
HLS Student Papers [559]
HLS Student Papers
Contact administrator regarding this item (to report mistakes or request changes)
